
Keywords: prostatic neoplasms; watchful waiting; neoplasm metastasis; risk factors; neoplasm gradingADT, androgen deprivation therapy; AS, active surveillance; DT, doubling time; GP, Gleason pattern; GS, Gleason score; PSA, prostate specific antigen; RP, radical pr